Работайте офлайн с приложением Player FM !
2021 ASH Annual Meeting: Plenary Abstract on ZUMA-7 Study, With Drs. Frederick Locke & Brad Kahl
Manage episode 313297616 series 2981732
In this installment of our 2021 ASH Annual Meeting Podcast series, Contributing Editor Dr. Brad Kahl has a conversation with Contributing Editor Dr. Frederick Locke about his work on one of the plenary abstracts that will be presented at the 2021 ASH Annual Meeting. The abstract presents an analysis of the ZUMA-7 trial of axicabtagene ciloleucel versus standard-of-care therapy in patients with relapsed/refractory large B-cell lymphoma.
For coverage of the plenary scientific session, including this abstract and many other sessions, check www.ashpublications.org/ashnewsdaily throughout the meeting.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
143 эпизодов
Manage episode 313297616 series 2981732
In this installment of our 2021 ASH Annual Meeting Podcast series, Contributing Editor Dr. Brad Kahl has a conversation with Contributing Editor Dr. Frederick Locke about his work on one of the plenary abstracts that will be presented at the 2021 ASH Annual Meeting. The abstract presents an analysis of the ZUMA-7 trial of axicabtagene ciloleucel versus standard-of-care therapy in patients with relapsed/refractory large B-cell lymphoma.
For coverage of the plenary scientific session, including this abstract and many other sessions, check www.ashpublications.org/ashnewsdaily throughout the meeting.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
143 эпизодов
Toate episoadele
×Добро пожаловать в Player FM!
Player FM сканирует Интернет в поисках высококачественных подкастов, чтобы вы могли наслаждаться ими прямо сейчас. Это лучшее приложение для подкастов, которое работает на Android, iPhone и веб-странице. Зарегистрируйтесь, чтобы синхронизировать подписки на разных устройствах.